切换至 "中华医学电子期刊资源库"

中华老年病研究电子杂志 ›› 2023, Vol. 10 ›› Issue (01) : 14 -19. doi: 10.3877/cma.j.issn.2095-8757.2023.01.003

临床研究

C反应蛋白与白蛋白比值和中性粒细胞与淋巴细胞比值对老年帕金森病的诊断价值
韩远远, 于紫涵, 杨玲, 程弘禹, 宋春杰()   
  1. 223800 江苏省宿迁市第一人民医院神经内科
  • 收稿日期:2022-08-01 出版日期:2023-02-28
  • 通信作者: 宋春杰

Diagnostic nalue of C-reactive protein/albumin ratio and neutrophil/lymphocyte ratio for Parkinson's disease in elderly patients

Yuanyuan Han, Zihan Yu, Ling Yang, Hongyu Cheng, Chunjie Song()   

  1. Department of Neurology, The Affiliated Suqian First Hospital of Nanjing Medical University, Suqian 223800, China
  • Received:2022-08-01 Published:2023-02-28
  • Corresponding author: Chunjie Song
引用本文:

韩远远, 于紫涵, 杨玲, 程弘禹, 宋春杰. C反应蛋白与白蛋白比值和中性粒细胞与淋巴细胞比值对老年帕金森病的诊断价值[J]. 中华老年病研究电子杂志, 2023, 10(01): 14-19.

Yuanyuan Han, Zihan Yu, Ling Yang, Hongyu Cheng, Chunjie Song. Diagnostic nalue of C-reactive protein/albumin ratio and neutrophil/lymphocyte ratio for Parkinson's disease in elderly patients[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2023, 10(01): 14-19.

目的

探讨C反应蛋白与白蛋白比值(CAR)和中性粒细胞与淋巴细胞比值(NLR)对老年帕金森病(PD)的诊断价值。

方法

选取2019年1月至2022年3月在宿迁市第一人民医院就诊的老年PD患者87例(PD组)及因头痛头晕来院检查者60名(对照组),收集两组患者的基本资料、血生化指标,计算CAR和NLR。采用Spearman相关性分析CAR和NLR与PD患者疾病严重程度(Hoehn-Yahr分期)和认知功能障碍的相关性;采用多因素Logistic回归分析确定CAR和NLR是否为PD发病的危险因素;利用受试者工作特征(ROC)曲线评估CAR和NLR对PD的诊断价值。

结果

与对照组相比,PD组患者CAR和NLR水平明显增高,差异具有统计学意义(t=3.875、3.212,均P<0.01)。Spearman相关性分析结果显示,CAR与PD患者Hoehn-Yahr分期及认知功能障碍均呈正相关(r=0.614和0.712,P<0.01),NLR仅与PD患者认知功能障碍呈正相关(r=0.735,P<0.01)。多因素Logistic回归分析结果显示,CAR和NLR是PD的独立危险因素(OR=2.533、1.736,95%CI:1.662~4.064、1.437~2.968,P<0.01)。ROC曲线分析结果显示,CAR和NLR预测PD的曲线下面积分别为0.749(95%CI:0.666~0.831,P<0.05)和0.751(95%CI:0.670~0.833,P<0.05),CAR和NLR联合预测PD的曲线下面积为0.837(95%CI:0.772~0.903,P<0.01)。

结论

CAR和NLR与PD的发病风险、疾病严重程度和认知功能障碍相关,可作为诊断PD的生物学标志物,两者联合诊断的价值更高。

Objective

To explore the diagnostic nalue of of C-reactive protein to albumin ratio (CAR) and neutrophil to lymphocyte ratio (NLR) for Parkinson's disease (PD) in elderly patients.

Methords

A total of 87 elderly PD patients (PD group) and 60 patients with headache and dizziness (Control group) were collected from Suqian First Hospital from January 2019 to March 2022. Basic data and blood biochemical indexes of patients in the two groups were collected, and CAR and NLR were calculated. Spearman correlation analysis was used to analyze the correlation of CAR and NLR with disease severity (Hoehn-Yahr stage) and cognitive dysfunction in PD patients. Multivariate logistic regression analysis was used to determine whether CAR and NLR were risk factors for PD. The diagnostic value of CAR and NLR for PD was evaluated using receiver operating characteristic (ROC) curve .

Results

Compared with the control group, the levels of CAR and NLR in PD group were significantly higher, and the difference was statistically significant (t=3.875, 3.212; P < 0.05). Spearman correlation analysis showed that CAR was positively correlated with Hoehn-Yahr stage and cognitive dysfunction in PD patients (r=0.614, 0.712; P < 0.01), while NLR was only positively correlated with cognitive dysfunction in PD patients (r=0.735, P < 0.01). Multivariate Logistic regression analysis showed that CAR and NLR were independent risk factors for PD (OR=2.533, 1.736; 95%CI: 1.662-4.064, 1.437-2.968; P < 0.01). ROC curve analysis results showed that the areas under the curve predicted by CAR and NLR were 0.749 (95%CI: 0.666-0.831, P < 0.05) and 0.751 (95%CI: 0.670-0.833, P < 0.05), respectively. The area under the curve predicted by CAR and NLR was 0.837(95%CI: 0.772-0.903, P < 0.01).

Conclusion

CAR and NLR are associated with the risk, severity and cognitive dysfunction of PD, and can be used as biomarkers to diagnose PD, and their combined diagnostic value is higher.

表1 两组患者基线资料的比较[例(%)或±s]
表2 不同Hoehn-Yahr分期老年帕金森病患者CAR和NLR的比较(±s
表3 伴或不伴认知功能障碍老年帕金森病患者CAR和NLR的比较(±s
表4 老年帕金森病多因素Logistic回归分析
图1 CAR和NLR诊断老年帕金森病的ROC曲线注:CAR指C反应蛋白与白蛋白比值;NLR指中性粒细胞与淋巴细胞比值;ROC曲线指受试者工作特征曲线
[1]
中华医学会神经病学分会帕金森病及运动障碍学组. 中国帕金森病的诊断标准(2016版)[J].中华神经科杂志201649(4):268-271.
[2]
Pajares M, Rojo AI, Manda G, et al. Inflammation in Parkinson's disease: Mechanisms and therapeutic implications[J]. Cells, 2020, 9(7):1687.
[3]
Marogianni C, Sokratous M, Dardiotis E, et al. Neurodegeneration and inflammation-An interesting interplay in Parkinson's disease[J]. Int J Mol Sci, 2020, 21(22):8421.
[4]
Sheinenzon A, Shehadeh M, Michelis R, et al. Serum albumin levels and inflammation[J]. Int J Biol Macromol, 2021, 184:857-862.
[5]
Kaplan M, Ates I, Akpinar MY, et al. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis[J]. Hepatobiliary Pancreat Dis Int, 2017, 16(4):424-430.
[6]
Güneş H, Yurttutan S, Çobanuşağı M, et al. CRP/albumin ratio: A promising marker of gram-negative bacteremia in late-onset neonatal sepsis[J]. Turk Arch Pediatr, 2021, 56(1):32-36.
[7]
Chen YH, Wang L, Feng SY, et al. The relationship between C-reactive protein/albumin ratio and disease activity in patients with inflammatory bowel disease[J]. Gastroenterol Res Pract, 2020, 2020:3467419.
[8]
Yildirim T, Kiris T, Avci E, et al. Increased serum CRP-albumin ratio is independently associated with severity of carotid artery stenosis[J]. Angiology, 2020, 71(8):740-746.
[9]
Faria SS, Fernandes PC Jr, Silva MJ, et al. The neutrophil-to-lymphocyte ratio: A narrative review[J]. Ecancermedicalscience, 2016, 10:702.
[10]
孙雪婷,李可为,余刚.帕金森病免疫炎症机制的研究进展[J].中华神经科杂志201952(8):670-673.
[11]
Baran A, Bulut M, Kaya MC, et al. High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease[J]. Neurol Sci, 2019, 40(1):167-173.
[12]
Akıl E, Bulut A, Kaplan İ, et al. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease[J]. Neurol Sci, 2015, 36(3):423-428.
[13]
Memar MY, Alizadeh N, Varshochi M, et al. Immunologic biomarkers for diagnostic of early-onset neonatal sepsis[J]. J Matern Fetal Neonatal Med, 2019, 32(1):143-153.
[14]
Pathak A, Agrawal A. Evolution of C-reactive protein[J]. Front Immunol, 2019, 10:943.
[15]
Qiu X, Xiao Y, Wu J, et al. C-reactive protein and risk of Parkinson's disease: A systematic review and meta-analysis[J]. Front Neurol, 2019,10:384.
[16]
Andican G, Konukoglu D, Bozluolcay M, et al. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease[J]. Acta Neurol Belg, 2012, 112(2):155-159.
[17]
Sawada H, Oeda T, Umemura A, et al. Baseline C-reactive protein levels and life prognosis in Parkinson's disease[J]. PLoS One, 2015, 10(7):e0134118.
[18]
Jin H, Gu HY, Mao CJ, et al. Association of inflammatory factors and aging in Parkinson's disease[J]. Neurosci Lett, 2020, 736:135259.
[19]
Wang L, Hu W, Wang J, et al. Impact of serum uric acid, albumin and their interaction on Parkinson's disease[J]. Neurol Sci, 2017,38(2):331-336.
[20]
Kakinen A, Javed I, Faridi A, et al. Serum albumin impedes the amyloid aggregation and hemolysis of human islet amyloid polypeptide and alpha synuclein[J]. Biochim Biophys Acta Biomembr, 2018, 1860(9):1803-1809.
[21]
Dong X, Nao J, Shi J, et al. Predictive value of routine peripheral blood biomarkers in Alzheimer's disease[J]. Front Aging Neurosci, 2019, 11:332.
[22]
Zenaro E, Pietronigro E, Della Bianca V, et al. Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin[J]. Nat Med, 2015, 21(8):880-886.
[23]
Choi SJ, Hong YH, Kim SM, et al. High neutrophil-to-lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis[J]. Sci Rep, 2020, 10(1):428.
[24]
Ohtani R, Nirengi S, Nakamura M, al. High-density lipoprotein subclasses and mild cognitive impairment: Study of outcome and a Polipoproteins in Dementia (STOP-Dementia)1[J]. J Alzheimers Dis, 2018, 66(1):289-296.
[25]
Halazun HJ, Mergeche JL, Mallon KA, et al. Neutrophil-lymphocyte ratio as a predictor of cognitive dysfunction in carotid endarterectomy patients[J]. J Vasc Surg, 2014, 59(3):768-773.
[26]
Kara SP, Altunan B, Unal A. Investigation of the peripheral inflammation (neutrophil-lymphocyte ratio) in two neurodegenerative diseases of the central nervous system[J]. Neurol Sci, 2021, 31:1-9.
[27]
Sharma D, Spring KJ, Bhaskar SMM. Neutrophil-lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis[J]. Acta Neurol Scand, 2021, 144(5):486-499.
[28]
Petrone AB, Eisenman RD, Steele KN, et al. Temporal dynamics of peripheral neutrophil and lymphocytes following acute ischemic stroke[J]. Neurol Sci, 2019, 40(9):1877-1885.
[1] 张巧梅, 孙小平, 李冠胜, 邓扬嘉. 针灸对大鼠呼吸机相关性肺炎中性粒细胞归巢及胞外诱捕网的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 265-271.
[2] 罗晨, 宗开灿, 李世颖, 傅应亚. 微小RNA-199a-3p调控CD4T细胞表达参与肺炎支原体肺炎患儿免疫反应研究[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 569-574.
[3] 陆美琪, 赵洁, 单菲, 王兴蕾, 姜笃银. 药物相关坏疽性脓皮病的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 447-450.
[4] 王龙彪, 刘洪, 董天雄. 中心体扩增细胞占比和C反应蛋白-白蛋白比值对胃癌根治术治疗预后的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 352-356.
[5] 张红凯, 崔建春. 从病理角度学习非哺乳期乳腺炎的分类分型及治疗[J]. 中华普通外科学文献(电子版), 2023, 17(04): 251-251.
[6] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[7] 王娟, 高俊, 周伊兰, 李小红, 史兵伟, 潘美珍. 血清IL-2、IL-17和骨密度关系及其对骨质疏松症的预测价值[J]. 中华老年骨科与康复电子杂志, 2023, 09(05): 295-300.
[8] 金刚, 李英真, 施维, 李博. 帕金森病在病理生理学中的研究进展[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 315-319.
[9] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
[10] 孙旻. 血液淀粉酶、C反应蛋白、降钙素原及乳酸脱氢酶在急性胰腺炎患者病情评价及预后预测中的价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 331-336.
[11] 吴萌, 吴国仲, 王贵红, 端靓靓, 施杰, 王旭, 余婷, 刘伟. IgA肾病患者中性粒细胞-淋巴细胞比值与肾小管萎缩/间质纤维化相关性分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 972-979.
[12] 耿磊, 张照婷, 许磊, 黄海, 孙毅, 杨伏猛, 徐凯, 胡春峰. 帕金森病前驱期基底神经节环路磁共振弥散张量成像的应用研究[J]. 中华临床医师杂志(电子版), 2023, 17(9): 995-1003.
[13] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
[14] 牛文博, 吴凤鹏, 刘月平, 周超熙, 张娟, 胡旭华, 李保坤, 王贵英. 新辅助放化疗对局部进展期直肠癌疗效及肿瘤免疫微环境变化的研究[J]. 中华临床医师杂志(电子版), 2023, 17(05): 519-523.
[15] 陈捷, 白易, 刘金波, 刘欢, 赵娜, 赵红薇, 王宏宇. 中老年人群中性粒细胞和高密度脂蛋白比值与下肢动脉疾病的相关性[J]. 中华临床医师杂志(电子版), 2023, 17(04): 402-408.
阅读次数
全文


摘要